WASHINGTON (Reuters) - Big tech companies, like YouTube owner Alphabet among many others, would face further limits on how they use children's data to.
The divestiture will be executed through a third-party sale or capital markets transaction, San Diego-based Illumina said in a statement, adding that it would finalize the terms by second quarter of 2024. Grail will continue to be held separate with committed funding from Illumina for the company's business through the divestment process, the former said in a separate statement. Grail, valued at $7.1 billion under Illumina's deal, is seeking to market a blood test that can diagnose many kinds of cancer, known as a liquid biopsy.
Illumina said on Sunday that
it would divest cancer diagnostic test maker Grail
after the companies battled both U.S. and European antitrust
enforcers for more than two years and faced fierce.
US court strikes down FTC order against Illumina's purchase of Grail By Reuters investing.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investing.com Daily Mail and Mail on Sunday newspapers.
By Diane Bartz and Mike Scarcella (Reuters) - A U.S. appeals court on Friday struck down the U.S. Federal Trade Commission's order against Illumina's .